SMITH; Paul William

Patent Applications and Registrations

Patent applications and USPTO patent grants for SMITH; Paul William.The latest application filed is for "indole carboxamide derivatives and uses thereof".

Company Profile

1.6.12

SMITH; Paul William - Didcot GB
Smith; Paul William - Singapore SG
Smith; Paul William - Harlow GB
Smith; Paul William - Essex GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Indole Carboxamide Derivatives And Uses Thereof App 20210032202 - JIRICEK; Jan ; et al.	2021-02-04
Indole Carboxamide Derivatives And Uses Thereof App 20160355477 - Jiricek; Jan ; et al.	2016-12-08
Indole carboxamide derivatives and uses thereof Grant 9,447,039 - Jiricek , et al. September 20, 2	2016-09-20
Indole Carboxamide Derivatives And Uses Thereof App 20150175539 - Jiricek; Jan ; et al.	2015-06-25
Compounds which have activity at M.sub.1 receptor and their uses in medicine Grant 8,288,412 - Budzik , et al. October 16, 2	2012-10-16
Benzimidazolones which have activity at M1 receptor Grant 8,288,413 - Budzik , et al. October 16, 2	2012-10-16
Compounds which have activity at M.sub.1 receptor and their uses in medicine Grant 8,283,364 - Budzik , et al. October 9, 2	2012-10-09
Benzimidazolones Which Have Activity at M1 Receptor App 20080306112 - Budzik; Brian ; et al.	2008-12-11
Compounds Which Have Activity at M1 Receptor and Their Uses In Medicine App 20080293770 - Budzik; Brian ; et al.	2008-11-27
Compounds Having Activity at Nk3 Receptor and Uses Thereof in Medicine App 20080261945 - Smith; Paul William ; et al.	2008-10-23
Compounds Which Have Activity at M1 Receptor and Their Uses in Medicine App 20080255195 - Budzik; Brian ; et al.	2008-10-16
Compounds Having Activity At Nk3 Receptor And Uses Thereof In Medicine App 20080103173 - Porter; Roderick Alan ; et al.	2008-05-01
Quinoline 4-carboxamide derivatives and their use as neurokinin 3 (nk-3) receptor antagonists App 20070142431 - Chan; Wai Ngor ; et al.	2007-06-21
2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors Grant 7,179,835 - Borthwick , et al. February 20, 2	2007-02-20
2-(3-Sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors App 20050004119 - Borthwick, Alan David ; et al.	2005-01-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.